NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for SyntheMed Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
SyntheMed Completes $1.0 Million Equity Placement
2009 OCT 13 ... SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and ...
Subject: SyntheMed, Inc.
Price: $3.00
*
SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
2009 JUN 8 ... Cardiac Surgery, Cardiology, Heart Surgery, Regulatory Actions, Therapy, Treatment, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Surgery
Price: $3.00
*
SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM)
2009 SEP 21 ... Keywords: Cardiac Surgery, Cardiology, Heart Surgery, Regulatory Actions, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff and ...
Subject: Surgery
Price: $3.00
*
AdvaMed 2008 Selects First Round of Company Presentations
2008 AUG 11 ... Seno Medical Instruments, Inc. of San Antonio, Texas • SyntheMed, Inc. of Iselin, New Jersey Specific time slots and locations for each ...
Subject: Life Sciences
Price: $3.00
*
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for Repel-CV
2007 APR 9 ... Clinical Trial Research, FDA, Regulatory Actions, U.S. Food and Drug Administration, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Cardiology
Price: $3.00
*
First Round of Companies to Present at AdvaMed 2008 Selected
2008 AUG 11 ... Seno Medical Instruments, Inc. of San Antonio, Texas • SyntheMed, Inc. of Iselin, New Jersey Specific time slots and locations of ...
Subject: Life Sciences
Price: $3.00
*
John Benson named controller of SyntheMed, Inc.
2006 OCT 9 ... SyntheMed, Inc. (SYMD) announced the appointment of John Benson to the newly created position of ...
Subject: Personnel
Price: $3.00
*
Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
2008 JUL 28 ... has 25 years of experience in the biomedical industry. He is currently Chairman of Synthemed, Inc., a publicly traded medical device company; and DMS Data Systems, an Internet-based ...
Subject: Biomedicine
Price: $3.00
*
SyntheMed Announces FDA Clearance of SinusShield(TM)
2008 DEC 3 ... SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced that it has received FDA 510(k) clearance to ...
Subject: SyntheMed, Inc.
Price: $3.00
*
SyntheMed announces positive trial results for REPEL-CV in neonatal heart surgery patients
2006 OCT 2 ... SyntheMed, Inc. (SYMD), a biomaterials company developing anti-adhesion and drug delivery ...
Subject: Cardiology
Price: $3.00
*
SyntheMed Appoints Marc Sportsman as Vice President of Sales
2007 MAY 14 ... SyntheMed will be featuring REPEL-CV." Keywords: Business, Personnel, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Personnel
Price: $3.00
*
SyntheMed Completes $2.8 Million Equity Financing
2007 AUG 27 ... Keywords: Bioengineering, Biotechnology, Business, Drug Delivery, Financing, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Bioengineering
Price: $3.00
*
SyntheMed officials announce the latest developments
2006 NOV 20 ... SyntheMed officials announce the latest developments. This trend article is an ... the most recent news developments at SyntheMed. Report 1: SyntheMed, Inc. (SYMD) announced the appointment of John Benson to the newly created position of ...
Subject: SyntheMed
Price: $3.00
*
SyntheMed Receives Canadian Approval for REPEL-CV(R)
2008 JUL 28 ... Surgery, Cardiology, Drug Delivery, Heart Surgery, Pediatric, Regulatory Actions, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Surgery
Price: $3.00
*
SyntheMed's Pre-Market Approval (PMA) Application for REPEL-CV to be Reviewed by FDA Panel
2007 JUL 2 ... Keywords: FDA, Regulatory Actions, U.S. Food and Drug Administration, SyntheMed Inc. This article was prepared by Biotech Business Week editors from staff ...
Subject: Regulatory Actions
Price: $3.00
*
SyntheMed, Inc. Adopts Shareholder Rights Plan
2008 JUN 3 ... SyntheMed, Inc. (BULLETIN BOARD: SYMD) announced that its Board of Directors approved the adoption ...
Subject: SyntheMed, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login